Skip to main content

2 Result(s)

within S. Filip Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Ex vivo expansion CD34+/AC133+ - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy

    AC133 antibody provides an alternative to CD34 for the selection and characterization of cells necessary for engraftment in transplant situations. We studied the effect of stem cell factor (SCF), interleukin 3...

    J. Vávrová, S. Filip, D. Vokurková, M. Bláha, J. Vanásek… in Hematology and Cell Therapy (1999)

  2. No Access

    Article

    Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection

    To support multicyclic, dose-intensive chemotherapy in breast cancer, we assessed the effects of reinfusing hematopoietic progenitors either as a leukapheresis product or as mobilized unprocessed whole blood. ...

    J Vaňásek, S Filip, V Medková, M Bláha, P Měřička, K Volenec in Bone Marrow Transplantation (1998)